Literature DB >> 26732558

Development of controlled release systems over the past 50years in the area of contraception.

David R Friend1.   

Abstract

The field of controlled release has contributed significantly to female reproductive health and in particular the prevention of unintended pregnancy. For at least 50years, there have been significant advances in controlled release dosage forms used for contraception. These advances have been driven by the need to provide women a wide array of products that address adherence problems noted with oral contraceptives. The first long-acting injectable product (Depo-Provera®) was approved in the US in 1959. Since then, there has been an emphasis on development of long-acting reversible contraceptives. These products include implants, intrauterine systems, and vaginal rings. A shorter acting contraceptive option is the transdermal patch. Despite these advances there are still a large number of unplanned pregnancies around the world. New controlled release technologies will be needed to continue providing women safe and easy to use contraceptive products.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Contraception; Implants; Injectable; Intrauterine systems; Intravaginal rings; Prevention of unintended pregnancy; Transdermal patches

Mesh:

Substances:

Year:  2015        PMID: 26732558     DOI: 10.1016/j.jconrel.2015.12.043

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  6 in total

1.  Manufacturing and characterization of long-acting levonorgestrel intrauterine systems.

Authors:  Quanying Bao; Bing Gu; Claire F Price; Yuan Zou; Yan Wang; Darby Kozak; Stephanie Choi; Diane J Burgess
Journal:  Int J Pharm       Date:  2018-09-05       Impact factor: 5.875

2.  Comparison of plasma etonogestrel concentrations sampled from the contralateral-to-implant and ipsilateral-to-implant arms of contraceptive implant users.

Authors:  Alida M Gertz; Ian J Bishop; Boikhutso Simon; Kwana Lechiile; Opelo Badubi; Aamirah Mussa; Carolyn L Westhoff; Chelsea Morroni
Journal:  Contraception       Date:  2020-08-26       Impact factor: 3.375

Review 3.  Drug delivery for the treatment of endometriosis and uterine fibroids.

Authors:  David R Friend
Journal:  Drug Deliv Transl Res       Date:  2017-12       Impact factor: 4.617

4.  Development of Porous Polyurethane Implants Manufactured via Hot-Melt Extrusion.

Authors:  Ioannis Koutsamanis; Martin Spoerk; Florian Arbeiter; Simone Eder; Eva Roblegg
Journal:  Polymers (Basel)       Date:  2020-12-10       Impact factor: 4.329

Review 5.  In Vitro Methods for Evaluating Drug Release of Vaginal Ring Formulations-A Critical Review.

Authors:  Katharina Tietz; Sandra Klein
Journal:  Pharmaceutics       Date:  2019-10-16       Impact factor: 6.321

6.  Diffuse Alveolar Hemorrhage after Receiving Oral Levonorgerstrel for Emergency Contraception: A Case Report.

Authors:  Athina Georgopoulou; Efthymia Papadopoulou; Marianna Moyseos; Sofia-Chrysovalantou Zagalioti; Christos Hatzis; Dimitrios Karanasios; Stavros Tryfon
Journal:  Clin Med Insights Case Rep       Date:  2021-03-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.